<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03227991</url>
  </required_header>
  <id_info>
    <org_study_id>7383</org_study_id>
    <nct_id>NCT03227991</nct_id>
  </id_info>
  <brief_title>Safety Planning Intervention to Reduce Short Term Risk</brief_title>
  <official_title>Safety Planning Intervention to Reduce Short Term Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Massachusetts, Worcester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Foundation for Suicide Prevention</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine the efficacy of Safety Planning Intervention (SPI) compared to&#xD;
      receiving risk factors and warning sign information (RWI) in recent suicide attempters during&#xD;
      the 6 months following an acute care visit on: (1) suicidal behaviors; (2) mental&#xD;
      health/substance use treatment engagement; (3) suicide-related coping strategies; (4)&#xD;
      suicidal ideation; and (5) use of means restriction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is a pressing need for improved acute care setting suicide prevention interventions.&#xD;
      The Safety Planning Intervention (SPI) is a protocol driven, brief suicide prevention&#xD;
      strategy that is a good fit for acute care settings (i.e., emergency departments (ED) and&#xD;
      inpatient units). The SPI involves a clinician working collaboratively with the patient to&#xD;
      build a personalized safety plan that is documented using a templated paper form and includes&#xD;
      warning sign identification, means restriction and personalized strategies to deescalate a&#xD;
      suicide crisis. It is easy to learn and administer, acceptable to patients, brief, firmly&#xD;
      rooted in an empirical base and has preliminary studies supporting its feasibility and&#xD;
      potential to impact patient outcomes, including suicidal behavior and treatment engagement.&#xD;
      However, while it is being adopted widely, it lacks a randomized controlled trial (RCT) to&#xD;
      definitively determine its efficacy. The purpose of this study to conduct a randomized&#xD;
      control trial of the Safety Planning Intervention (SPI) compared with receiving risk factors&#xD;
      and warning sign information (RWI) in acute care settings.&#xD;
&#xD;
      All participants in this study will complete some baseline assessments, following which they&#xD;
      will be randomly assigned to one of two study conditions: Safety Plan Intervention (SPI) or&#xD;
      receiving risk factors and warning sign information (RWI). If assigned to SPI, participants&#xD;
      will receive the assigned intervention by the research clinician. They will receive a paper&#xD;
      copy of their safety plan while in the ED or on the inpatient unit and a back-up copy will be&#xD;
      sent approximately 1 week after discharge to participants. For RWI participants, ED and&#xD;
      inpatient unit care will be delivered as usual, with the addition of a printed information&#xD;
      sheet listing suicide risk factors and crisis hotlines. In addition to the baseline&#xD;
      assessment, multi-method outcome assessment will be conducted at 1, 3, and 6 months. This&#xD;
      will include telephone evaluations by a blinded assessor (not the research clinician),&#xD;
      medical record review, and vital statistics registry review.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 10, 2017</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Suicide, attempted and suicide</measure>
    <time_frame>1 month</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Suicide, attempted and suicide</measure>
    <time_frame>3 months</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Suicide, attempted and suicide</measure>
    <time_frame>6 months</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Suicide, attempted, aborted, interrupted attempt or preparatory suicidal behavior</measure>
    <time_frame>1 month</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicide, attempted, aborted, interrupted attempt or preparatory suicidal behavior</measure>
    <time_frame>3 months</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicide, attempted, aborted, interrupted attempt or preparatory suicidal behavior</measure>
    <time_frame>6 months</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Means restriction</measure>
    <time_frame>1 month</time_frame>
    <description>As measured by patient report about reducing access to lethal means</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Means restriction</measure>
    <time_frame>3 months</time_frame>
    <description>As measured by patient report about reducing access to lethal means</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Means restriction</measure>
    <time_frame>6 months</time_frame>
    <description>As measured by patient report about reducing access to lethal means</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicide related coping</measure>
    <time_frame>1 month</time_frame>
    <description>As measured by the total score on the Suicide-Related Coping Measure, a scale developed by Stanley, Brown and Holloway (2010). The scale is a 21 item self-report measure using a Likert scale. Examples of items are: &quot;I am at the mercy of my suicidal thoughts.&quot; and &quot;I have several things I can do to get through a suicidal crisis.&quot; The scale has high in internal reliability (Cronbach's alpha = .88), and, as predicted, moderate convergent validity with help-seeking attitudes (r = .47) and divergent validity with a pain measure (r= -.31). It is also sensitive to change (t(65) = 6.8, p &lt; .001).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicide related coping</measure>
    <time_frame>3 months</time_frame>
    <description>As measured by the total score on the Suicide-Related Coping Measure, a scale developed by Stanley, Brown and Holloway (2010). The scale is a 21 item self-report measure using a Likert scale. Examples of items are: &quot;I am at the mercy of my suicidal thoughts.&quot; and &quot;I have several things I can do to get through a suicidal crisis.&quot; The scale has high in internal reliability (Cronbach's alpha = .88), and, as predicted, moderate convergent validity with help-seeking attitudes (r = .47) and divergent validity with a pain measure (r= -.31). It is also sensitive to change (t(65) = 6.8, p &lt; .001).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicide related coping</measure>
    <time_frame>6 months</time_frame>
    <description>As measured by the total score on the Suicide-Related Coping Measure, a scale developed by Stanley, Brown and Holloway (2010). The scale is a 21 item self-report measure using a Likert scale. Examples of items are: &quot;I am at the mercy of my suicidal thoughts.&quot; and &quot;I have several things I can do to get through a suicidal crisis.&quot; The scale has high in internal reliability (Cronbach's alpha = .88), and, as predicted, moderate convergent validity with help-seeking attitudes (r = .47) and divergent validity with a pain measure (r= -.31). It is also sensitive to change (t(65) = 6.8, p &lt; .001).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment engagement</measure>
    <time_frame>1 month</time_frame>
    <description>As measured by attending one of more mental health/substance abuse treatment appointments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment engagement</measure>
    <time_frame>3 months</time_frame>
    <description>As measured by attending one of more mental health/substance abuse treatment appointments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment engagement</measure>
    <time_frame>6 months</time_frame>
    <description>As measured by attending one of more mental health/substance abuse treatment appointments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicidal ideation intensity</measure>
    <time_frame>1 month</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 1-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicidal ideation intensity</measure>
    <time_frame>3 months</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 1-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicidal ideation intensity</measure>
    <time_frame>6 months</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 1-5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicidal ideation severity</measure>
    <time_frame>1 month</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 2-25 with higher scores more severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicidal ideation severity</measure>
    <time_frame>3 months</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 2-25 with higher scores more severe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suicidal ideation severity</measure>
    <time_frame>6 months</time_frame>
    <description>As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 2-25 with higher scores more severe</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">422</enrollment>
  <condition>Suicide, Attempted</condition>
  <arm_group>
    <arm_group_label>Safety Planning Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SPI is a personalized approach that focuses on early identification of warning signs and execution of systematic steps to manage suicidal thoughts, created collaboratively by the patient and clinician.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Risk factors and Warning signs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a generic suicide risk factors and warning signs information handout.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Safety Planning Intervention</intervention_name>
    <description>The Safety Planning Intervention is a protocol driven, brief suicide prevention strategy that is a good fit for acute care settings. It involves a clinician working collaboratively with the patient to build a personalized safety plan that is documented using a templated paper form and includes warning sign identification, means restriction and personalized strategies to deescalate a suicide crisis.</description>
    <arm_group_label>Safety Planning Intervention</arm_group_label>
    <other_name>SPI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Risk factors and Warning signs</intervention_name>
    <description>Printed information sheet listing suicide risk factors and crisis hotlines</description>
    <arm_group_label>Risk factors and Warning signs</arm_group_label>
    <other_name>RWI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Presented for an acute care visit within 8 weeks of a suicide attempt, interrupted or&#xD;
             aborted attempt, or suicidal ideation with intent and plan within 4 weeks.&#xD;
&#xD;
          2. Are 18 years of age or older&#xD;
&#xD;
          3. Able to speak and read English&#xD;
&#xD;
          4. Able to understand the nature of the study, provide written informed consent, and&#xD;
             complete study procedures&#xD;
&#xD;
          5. Have been evaluated by a health care professional who provides permission for research&#xD;
             staff to approach the patient.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Under 18 years of age&#xD;
&#xD;
          2. Cannot speak or read English&#xD;
&#xD;
          3. Unable to understand the nature of the study, provide written informed consent, or&#xD;
             complete study procedures&#xD;
&#xD;
          4. Unable or unwilling to provide a personal phone number for follow up purposes.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara H Stanley, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York State Psychiatric Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Massachusetts</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York State Psychiatric Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>December 15, 2016</study_first_submitted>
  <study_first_submitted_qc>July 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2017</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York State Psychiatric Institute</investigator_affiliation>
    <investigator_full_name>Barbara Stanley</investigator_full_name>
    <investigator_title>Professor of Medical Psychology and Research Scientist</investigator_title>
  </responsible_party>
  <keyword>Suicide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Suicide</mesh_term>
    <mesh_term>Suicide, Attempted</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03227991
org study id: 7383
nct id: NCT03227991
lead sponsor: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
has dmc: Yes
is fda regulated drug: No
is fda regulated device: No
This study will determine the efficacy of Safety Planning Intervention (SPI) compared to
      receiving risk factors and warning sign information (RWI) in recent suicide attempters during
      the 6 months following an acute care visit on: (1) suicidal behaviors; (2) mental
      health/substance use treatment engagement; (3) suicide-related coping strategies; (4)
      suicidal ideation; and (5) use of means restriction.
There is a pressing need for improved acute care setting suicide prevention interventions.
      The Safety Planning Intervention (SPI) is a protocol driven, brief suicide prevention
      strategy that is a good fit for acute care settings (i.e., emergency departments (ED) and
      inpatient units). The SPI involves a clinician working collaboratively with the patient to
      build a personalized safety plan that is documented using a templated paper form and includes
      warning sign identification, means restriction and personalized strategies to deescalate a
      suicide crisis. It is easy to learn and administer, acceptable to patients, brief, firmly
      rooted in an empirical base and has preliminary studies supporting its feasibility and
      potential to impact patient outcomes, including suicidal behavior and treatment engagement.
      However, while it is being adopted widely, it lacks a randomized controlled trial (RCT) to
      definitively determine its efficacy. The purpose of this study to conduct a randomized
      control trial of the Safety Planning Intervention (SPI) compared with receiving risk factors
      and warning sign information (RWI) in acute care settings.

      All participants in this study will complete some baseline assessments, following which they
      will be randomly assigned to one of two study conditions: Safety Plan Intervention (SPI) or
      receiving risk factors and warning sign information (RWI). If assigned to SPI, participants
      will receive the assigned intervention by the research clinician. They will receive a paper
      copy of their safety plan while in the ED or on the inpatient unit and a back-up copy will be
      sent approximately 1 week after discharge to participants. For RWI participants, ED and
      inpatient unit care will be delivered as usual, with the addition of a printed information
      sheet listing suicide risk factors and crisis hotlines. In addition to the baseline
      assessment, multi-method outcome assessment will be conducted at 1, 3, and 6 months. This
      will include telephone evaluations by a blinded assessor (not the research clinician),
      medical record review, and vital statistics registry review.
allocation: Randomized
intervention model: Parallel Assignment
primary purpose: Prevention
masking: Single (Outcomes Assessor)
measure: Suicide, attempted and suicide
time frame: 1 month
description: As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe
measure: Suicide, attempted and suicide
time frame: 3 months
description: As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe
measure: Suicide, attempted and suicide
time frame: 6 months
description: As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe
measure: Suicide, attempted, aborted, interrupted attempt or preparatory suicidal behavior
time frame: 1 month
description: As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe
measure: Suicide, attempted, aborted, interrupted attempt or preparatory suicidal behavior
time frame: 3 months
description: As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe
measure: Suicide, attempted, aborted, interrupted attempt or preparatory suicidal behavior
time frame: 6 months
description: As measured by the Columbia Suicide Severity Rating Scale (C-SSRS); responses are yes-no with yes more severe
measure: Means restriction
time frame: 1 month
description: As measured by patient report about reducing access to lethal means
measure: Means restriction
time frame: 3 months
description: As measured by patient report about reducing access to lethal means
measure: Means restriction
time frame: 6 months
description: As measured by patient report about reducing access to lethal means
measure: Suicide related coping
time frame: 1 month
description: As measured by the total score on the Suicide-Related Coping Measure, a scale developed by Stanley, Brown and Holloway (2010). The scale is a 21 item self-report measure using a Likert scale. Examples of items are: "I am at the mercy of my suicidal thoughts." and "I have several things I can do to get through a suicidal crisis." The scale has high in internal reliability (Cronbach's alpha = .88), and, as predicted, moderate convergent validity with help-seeking attitudes (r = .47) and divergent validity with a pain measure (r= -.31). It is also sensitive to change (t(65) = 6.8, p < .001).
measure: Suicide related coping
time frame: 3 months
description: As measured by the total score on the Suicide-Related Coping Measure, a scale developed by Stanley, Brown and Holloway (2010). The scale is a 21 item self-report measure using a Likert scale. Examples of items are: "I am at the mercy of my suicidal thoughts." and "I have several things I can do to get through a suicidal crisis." The scale has high in internal reliability (Cronbach's alpha = .88), and, as predicted, moderate convergent validity with help-seeking attitudes (r = .47) and divergent validity with a pain measure (r= -.31). It is also sensitive to change (t(65) = 6.8, p < .001).
measure: Suicide related coping
time frame: 6 months
description: As measured by the total score on the Suicide-Related Coping Measure, a scale developed by Stanley, Brown and Holloway (2010). The scale is a 21 item self-report measure using a Likert scale. Examples of items are: "I am at the mercy of my suicidal thoughts." and "I have several things I can do to get through a suicidal crisis." The scale has high in internal reliability (Cronbach's alpha = .88), and, as predicted, moderate convergent validity with help-seeking attitudes (r = .47) and divergent validity with a pain measure (r= -.31). It is also sensitive to change (t(65) = 6.8, p < .001).
measure: Treatment engagement
time frame: 1 month
description: As measured by attending one of more mental health/substance abuse treatment appointments
measure: Treatment engagement
time frame: 3 months
description: As measured by attending one of more mental health/substance abuse treatment appointments
measure: Treatment engagement
time frame: 6 months
description: As measured by attending one of more mental health/substance abuse treatment appointments
measure: Suicidal ideation intensity
time frame: 1 month
description: As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 1-5
measure: Suicidal ideation intensity
time frame: 3 months
description: As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 1-5
measure: Suicidal ideation intensity
time frame: 6 months
description: As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 1-5
measure: Suicidal ideation severity
time frame: 1 month
description: As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 2-25 with higher scores more severe
measure: Suicidal ideation severity
time frame: 3 months
description: As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 2-25 with higher scores more severe
measure: Suicidal ideation severity
time frame: 6 months
description: As measured by the Columbia Suicide Severity Rating Scale (CSSRS) on a scale from 2-25 with higher scores more severe
arm group label: Safety Planning Intervention
arm group type: Active Comparator
description: SPI is a personalized approach that focuses on early identification of warning signs and execution of systematic steps to manage suicidal thoughts, created collaboratively by the patient and clinician.
arm group label: Risk factors and Warning signs
arm group type: Active Comparator
description: Patients will receive a generic suicide risk factors and warning signs information handout.
intervention type: Behavioral
intervention name: Safety Planning Intervention
description: The Safety Planning Intervention is a protocol driven, brief suicide prevention strategy that is a good fit for acute care settings. It involves a clinician working collaboratively with the patient to build a personalized safety plan that is documented using a templated paper form and includes warning sign identification, means restriction and personalized strategies to deescalate a suicide crisis.
arm group label: Safety Planning Intervention
other name: SPI
intervention type: Behavioral
intervention name: Risk factors and Warning signs
description: Printed information sheet listing suicide risk factors and crisis hotlines
arm group label: Risk factors and Warning signs
other name: RWI
criteria: 
gender: All
minimum age: 18 Years
maximum age: N/A
healthy volunteers: No
last name: Barbara H Stanley, Ph.D.
role: Principal Investigator
affiliation: New York State Psychiatric Institute
facility: 
facility: 
facility: 
country: United States
responsible party type: Principal Investigator
investigator affiliation: New York State Psychiatric Institute
investigator full name: Barbara Stanley
investigator title: Professor of Medical Psychology and Research Scientist
mesh term: Suicide
mesh term: Suicide, Attempted
sharing ipd: No